Modification to the A11 HERV-E TCR and T cell product to improve the therapeutic efficacy for ccRCC patients.

NATIONAL INSTITUTES OF HEALTH OLAOHEALTH AND HUMAN SERVICES, DEPARTMENT OF / NATIONAL INSTITUTES OF HEALTH / NATIONAL INSTITUTES OF HEALTH OLAO

Posted

May 19, 2026

Response deadline

Jun 3, 2026, 9:00 AM EDT

Due in 2 days

Value

—

Category

Hospitals / Medical

NAICS

622110

PSC / Class

R499

Set-aside

—

Place of performance

Bethesda, Maryland

Solicitation #

75N98026Q00392

Archive date

Jun 4, 2026